We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
RadNet
RDNT
$5.27B
| $2.63M | ﹤0.01% |
129,820
+74,757
| +136% | +$1.28M |
|
|
DBD
1652
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.63M | ﹤0.01% |
249,445
+11,739
| +5% | +$104K |
|
1653
Hilton Grand Vacations
HGV
$3.66B
| $2.63M | ﹤0.01% |
76,509
+101
| +0.1% | +$3.47K |
|
|
CCF
1654
DELISTED
Chase Corporation
CCF
| $2.63M | ﹤0.01% |
22,195
-67
| -0.3% | -$7.78K |
|
|
WPG
1655
DELISTED
Washington Prime Group Inc.
WPG
| $2.62M | ﹤0.01% |
80,030
+6,041
| +8% | +$219K |
|
1656
Shutterstock
SSTK
$229M
| $2.62M | ﹤0.01% |
61,098
+3,741
| +7% | +$150K |
|
1657
Elastic
ESTC
$7.25B
| $2.6M | ﹤0.01% |
40,390
+1,144
| +3% | +$83.9K |
|
|
PTLA
1658
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.59M | ﹤0.01% |
108,464
+9,601
| +10% | +$265K |
|
|
NXGN
1659
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.59M | ﹤0.01% |
161,131
+8,046
| +5% | +$133K |
|
1660
Enova International
ENVA
$6.55B
| $2.59M | ﹤0.01% |
107,462
+5,819
| +6% | +$131K |
|
1661
Copa Holdings
CPA
$6.15B
| $2.58M | ﹤0.01% |
23,886
+75
| +0.3% | +$7.82K |
|
|
DNR
1662
DELISTED
Denbury Resources, Inc.
DNR
| $2.58M | ﹤0.01% |
1,827,071
+99,107
| +6% | +$111K |
|
|
NAV
1663
DELISTED
Navistar International
NAV
| $2.57M | ﹤0.01% |
88,904
+5,211
| +6% | +$160K |
|
1664
Huron Consulting
HURN
$2.38B
| $2.57M | ﹤0.01% |
37,430
+584
| +2% | +$38K |
|
1665
Hanmi Financial
HAFC
$961M
| $2.56M | ﹤0.01% |
128,097
+4,312
| +3% | +$83.2K |
|
1666
Range Resources
RRC
$8.91B
| $2.56M | ﹤0.01% |
527,894
+31,794
| +6% | +$128K |
|
|
CMO
1667
DELISTED
Capstead Mortgage Corp.
CMO
| $2.55M | ﹤0.01% |
321,452
+16,202
| +5% | +$125K |
|
1668
Kelly Services Class A
KELYA
$528M
| $2.53M | ﹤0.01% |
111,998
+5,288
| +5% | +$119K |
|
|
MIC
1669
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $2.52M | ﹤0.01% |
58,796
+1,269
| +2% | +$52.4K |
|
|
NFBK
1670
DELISTED
Northfield Bancorp
NFBK
| $2.52M | ﹤0.01% |
148,280
+5,024
| +4% | +$84.4K |
|
1671
Alkermes
ALKS
$8.32B
| $2.51M | ﹤0.01% |
123,219
+1,571
| +1% | +$31.2K |
|
1672
Lakeland Financial Corp
LKFN
$1.57B
| $2.51M | ﹤0.01% |
51,277
+398
| +0.8% | +$18.5K |
|
1673
Genesco
GCO
$436M
| $2.5M | ﹤0.01% |
52,226
-973
| -2% | -$40.4K |
|
1674
Dillards
DDS
$9.63B
| $2.5M | ﹤0.01% |
33,983
-1,005
| -3% | -$71.2K |
|
1675
Lantheus
LNTH
$6.63B
| $2.49M | ﹤0.01% |
121,601
+6,598
| +6% | +$133K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.